Session translationnelle #2 : Oncologie et hématologie
lundi 12 juin 2023
Sessions translationnelles
Sessions translationnelles
•
S11
•
13h30
>
15h00
•
Session translationnelle #2 : Oncologie et hématologie
•
Amphi 400 B
Sessions translationnelles
Modérateurs : Fabien DESPAS (Toulouse), Théodora BEJAN-ANGOULVANT (Tours)
Conférence invitée
13h30 Approches translationnelles en onco-pharmacologie : l'exemple de la myocardite immuno-induite - Charles DOLLADILLE (Caen)
Communications libres
•
26
•
14h00 - CO-007 - Real-world treatment patterns in French metastatic castration-resistant prostate cancer patients under abiraterone or enzalutamide.
>
L-M.
Lucie-Marie
Scailteux
•
32
•
14h10 - CO-008 - JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms
>
N.
Nabih
Maslah
•
47
•
14h20 - CO-009 - Discrepancies between DPD phenotype and genotype: what are the explanatory factors?
>
C.
Capucine
Arrivé
•
166
•
14h30 - CO-010 - Next Generation Sequencing versus multiplex-genotyping for preemptive pharmacogenetics in oncology
>
D.
Dorian
Chastagner
•
346
•
14h40 - CO-011 - How many patients with cancer associated thrombosis, would be eligible for a randomized controlled trial evaluating a direct oral anticoagulant in routine clinical practice?
>
G.
Géraldine
Poenou
•
388
•
14h50 - CO-012 - Meta-analysis of phase I dose-finding studies: application for protein kinase inhibitors developed in oncology
>
L.
Laura
Caquelin
|